HLA-DRB1 and myeloid sarcoma: In one study humanised mice that were immune reconstituted from HLA-DRB1*15:01+ donors had increased steady state activation of CD4+ and CD8+ T cells and poor virus control evidenced by high EBV viral loads, compared to mice which were reconstituted with an allele not associated with increased MS risk (155).